Elutia (NASDAQ:ELUT – Get Free Report) will be announcing its earnings results after the market closes on Wednesday, August 7th. Investors that wish to register for the company’s conference call can do so using this link.
Elutia (NASDAQ:ELUT – Get Free Report) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.75) earnings per share (EPS) for the quarter. The business had revenue of $6.69 million during the quarter.
Elutia Price Performance
Shares of Elutia stock traded up $0.25 during trading hours on Tuesday, hitting $2.98. The company’s stock had a trading volume of 22,074 shares, compared to its average volume of 42,956. Elutia has a 12 month low of $1.10 and a 12 month high of $5.24. The stock has a 50 day moving average of $3.83 and a 200 day moving average of $3.50. The company has a market capitalization of $72.32 million, a PE ratio of -1.27 and a beta of 0.72.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on ELUT
About Elutia
Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.
Recommended Stories
- Five stocks we like better than Elutia
- What is a Dividend King?
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- What Are Dividend Achievers? An Introduction
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- Following Congress Stock Trades
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for Elutia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elutia and related companies with MarketBeat.com's FREE daily email newsletter.